News on Mendelian diseases, hereditary cancer, variant classification, cystic fibrosis testing and more.
The Hong Kong government has initially earmarked HK$682 million (US$87 million) and an average of HK$87 million per year for six years for the project.
Within the country's first whole-genome sequencing program, researchers hope to initially focus on identifying markers associated with hereditary diseases and cancer risk.
The company has begun piloting the software, which is targeted towards bioinformatics companies and clinical laboratories, with early adopters ahead of the planned launch.
The acquisition is expected to enhance Health Network Laboratories’ inherited genetic disorders diagnostic services offerings.
The analysis found that charges for suspected genetic diseases account for between 11 percent and 46 percent of pediatric healthcare costs in the US.
